Xenon Pharmaceuticals Inc. (XENE) stock analysis

XENE · Xenon Pharmaceuticals Inc.

Latest recorded price: USD 39.26

Sector and industry: Healthcare · Biotechnology

Fiscal 2018 figures: revenue growth -72.9%, free cash flow margin -11,328.3%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare